Latest Insider Transactions at Teva Pharmaceutical Industries LTD (TEVA)
This section provides a real-time view of insider transactions for Teva Pharmaceutical Industries LTD (TEVA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of TEVA PHARMACEUTICAL INDUSTRIES LTD to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of TEVA PHARMACEUTICAL INDUSTRIES LTD's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 04
2022
|
Richard Daniell Exec. VP, European Commercial |
SELL
Open market or private sale
|
Direct |
36,376
-38.06%
|
$254,632
$7.48 P/Share
|
Mar 04
2022
|
Richard Daniell Exec. VP, European Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
59,278
+35.53%
|
-
|
Mar 04
2022
|
Sven Dethlefs EVP, North America Commercial |
SELL
Open market or private sale
|
Direct |
3,904
-2.58%
|
$27,328
$7.48 P/Share
|
Mar 04
2022
|
Sven Dethlefs EVP, North America Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
51,869
+15.03%
|
-
|
Mar 04
2022
|
Eric Drape Executive VP Global Operations |
SELL
Open market or private sale
|
Direct |
23,458
-15.26%
|
$164,206
$7.48 P/Share
|
Mar 04
2022
|
Eric Drape Executive VP Global Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
44,458
+21.68%
|
-
|
Mar 04
2022
|
Hafrun Fridriksdottir Executive VP, Global R&D |
SELL
Open market or private sale
|
Direct |
24,638
-10.51%
|
$172,466
$7.48 P/Share
|
Mar 04
2022
|
Hafrun Fridriksdottir Executive VP, Global R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
70,393
+22.19%
|
-
|
Mar 04
2022
|
Mark Sabag EVP, International Markets |
BUY
Exercise of conversion of derivative security
|
Direct |
59,278
+17.29%
|
-
|
Mar 04
2022
|
Kare Schultz President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
222,294
+7.74%
|
-
|
Mar 04
2022
|
Eli Shani EVP,Global Marketing&Portfolio |
BUY
Exercise of conversion of derivative security
|
Direct |
3,173
+20.55%
|
-
|
Mar 04
2022
|
David Matthew Stark Exec. VP Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
23,254
-19.89%
|
$162,778
$7.48 P/Share
|
Mar 04
2022
|
David Matthew Stark Exec. VP Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
51,869
+29.43%
|
-
|
Mar 04
2022
|
Amir Weiss Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,403
+10.27%
|
-
|
Mar 02
2022
|
Amir Weiss Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
981
+5.01%
|
-
|
Feb 28
2022
|
Richard Daniell Exec. VP, European Commercial |
SELL
Open market or private sale
|
Direct |
20,598
-50.39%
|
$164,784
$8.14 P/Share
|
Feb 28
2022
|
Richard Daniell Exec. VP, European Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
20,598
+33.51%
|
-
|
Feb 28
2022
|
Sven Dethlefs EVP, North America Commercial |
SELL
Open market or private sale
|
Direct |
4,862
-4.66%
|
$38,896
$8.14 P/Share
|
Feb 28
2022
|
Sven Dethlefs EVP, North America Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
17,346
+14.26%
|
-
|
Feb 28
2022
|
Eric Drape Executive VP Global Operations |
SELL
Open market or private sale
|
Direct |
9,797
-17.61%
|
$78,376
$8.14 P/Share
|
Feb 28
2022
|
Eric Drape Executive VP Global Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
19,514
+25.97%
|
-
|
Feb 28
2022
|
Hafrun Fridriksdottir Executive VP, Global R&D |
SELL
Open market or private sale
|
Direct |
7,590
-10.38%
|
$60,720
$8.14 P/Share
|
Feb 28
2022
|
Hafrun Fridriksdottir Executive VP, Global R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
21,682
+22.88%
|
-
|
Feb 28
2022
|
Galia Inbar Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,828
+33.33%
|
-
|
Feb 28
2022
|
Eliyahu Sharon Kalif EVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,430
+29.76%
|
-
|
Feb 28
2022
|
Mark Sabag EVP, International Markets |
BUY
Exercise of conversion of derivative security
|
Direct |
20,598
+17.88%
|
-
|
Feb 28
2022
|
Kare Schultz President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
65,047
+5.43%
|
-
|
Feb 28
2022
|
Eli Shani EVP,Global Marketing&Portfolio |
SELL
Open market or private sale
|
Direct |
5,311
-36.88%
|
$42,488
$8.14 P/Share
|
Feb 28
2022
|
Eli Shani EVP,Global Marketing&Portfolio |
BUY
Exercise of conversion of derivative security
|
Direct |
5,311
+26.94%
|
-
|
Feb 28
2022
|
David Matthew Stark Exec. VP Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
6,452
-23.18%
|
$51,616
$8.14 P/Share
|
Feb 28
2022
|
David Matthew Stark Exec. VP Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,430
+39.84%
|
-
|
Feb 28
2022
|
Amir Weiss Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,219
+15.45%
|
-
|
Feb 13
2022
|
Eliyahu Sharon Kalif EVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,629
+20.92%
|
-
|
Feb 09
2022
|
Richard Daniell Exec. VP, European Commercial |
SELL
Open market or private sale
|
Direct |
13,135
-39.31%
|
$118,215
$9.06 P/Share
|
Feb 09
2022
|
Richard Daniell Exec. VP, European Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
13,135
+28.22%
|
-
|
Feb 09
2022
|
Sven Dethlefs EVP, North America Commercial |
SELL
Open market or private sale
|
Direct |
4,138
-4.54%
|
$37,242
$9.06 P/Share
|
Feb 09
2022
|
Sven Dethlefs EVP, North America Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
13,135
+12.6%
|
-
|
Feb 09
2022
|
Eric Drape Executive VP Global Operations |
SELL
Open market or private sale
|
Direct |
3,583
-9.03%
|
$32,247
$9.06 P/Share
|
Feb 09
2022
|
Eric Drape Executive VP Global Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
6,568
+14.2%
|
-
|
Feb 09
2022
|
Hafrun Fridriksdottir Executive VP, Global R&D |
SELL
Open market or private sale
|
Direct |
6,116
-10.63%
|
$55,044
$9.06 P/Share
|
Feb 09
2022
|
Hafrun Fridriksdottir Executive VP, Global R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
16,121
+21.89%
|
-
|
Feb 09
2022
|
Mark Sabag EVP, International Markets |
BUY
Exercise of conversion of derivative security
|
Direct |
15,523
+17.34%
|
-
|
Feb 09
2022
|
Kare Schultz President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
26,867
+2.46%
|
-
|
Feb 09
2022
|
David Matthew Stark Exec. VP Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
6,110
-39.39%
|
$54,990
$9.06 P/Share
|
Feb 09
2022
|
David Matthew Stark Exec. VP Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,538
+44.7%
|
-
|
Nov 01
2021
|
Kare Schultz President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
180,000
+14.75%
|
-
|
Aug 10
2021
|
Hafrun Fridriksdottir Executive VP, Global R&D |
SELL
Open market or private sale
|
Direct |
50,860
-55.12%
|
$457,740
$9.95 P/Share
|
Jun 09
2021
|
Ronit Satchi Fainaro |
BUY
Acquisition or disposition by will or laws
|
Direct |
550
+1.47%
|
-
|
Jun 09
2021
|
Sol J Barer |
BUY
Exercise of conversion of derivative security
|
Direct |
22,565
+6.63%
|
-
|
Jun 09
2021
|
Rosemary A Crane |
BUY
Exercise of conversion of derivative security
|
Direct |
12,668
+19.52%
|
-
|